Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Olsson

Showing results (101-110 of 109) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 109 results.
Leukemia|May 3, 2017
No increased prevalence of malignancies among first-degree relatives of 800 patients with chronic myeloid leukemia: a population-based study in SwedenN Gunnarsson, M Höglund, L Stenke, et al.
Journal of Synchrotron Radiation|June 19, 2009
A new small-angle X-ray scattering set-up on the crystallography beamline I711 at MAX-labM Knaapila, C Svensson, J Barauskas, et al.
Journal of Evolutionary Biology|February 11, 2012
Single origin of human commensalism in the house sparrowGlenn-Peter Sætre, S Riyahi, M Aliabadian, et al.
Leukemia|April 16, 2016
Increased prevalence of prior malignancies and autoimmune diseases in patients diagnosed with chronic myeloid leukemiaN Gunnarsson, M Höglund, L Stenke, et al.
Immuno-Oncology Technology|March 11, 2026
Safety of intratumoral immunostimulatory LOAd703 gene therapy combined with chemotherapy in patients with advanced cancerA Hahn, S Irenaeus, L C Sandin, et al.
Leukemia|May 3, 2016
Safety and efficacy of the combination of pegylated interferon-α2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patientsH Hjorth-Hansen, J Stentoft, J Richter, et al.
Leukemia|January 19, 2013
Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patientsS Mustjoki, J Richter, G Barbany, et al.
Leukemia|June 18, 2026
Comprehensive molecular characterization of treatment-free remission and molecular relapse in chronic myeloid leukemia patients: the EURO-SKI Biomarker StudyS Rinaldetti, M Chepeleva, A Hedblom, et al.
Leukemia|November 29, 2016
Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemiaM Ilander, U Olsson-Strömberg, H Schlums, et al.
Pageof 11

Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
Leukemia|May 3, 2017
No increased prevalence of malignancies among first-degree relatives of 800 patients with chronic myeloid leukemia: a population-based study in SwedenN Gunnarsson, M Höglund, L Stenke, et al.
Journal of Synchrotron Radiation|June 19, 2009
A new small-angle X-ray scattering set-up on the crystallography beamline I711 at MAX-labM Knaapila, C Svensson, J Barauskas, et al.
Journal of Evolutionary Biology|February 11, 2012
Single origin of human commensalism in the house sparrowGlenn-Peter Sætre, S Riyahi, M Aliabadian, et al.
Leukemia|April 16, 2016
Increased prevalence of prior malignancies and autoimmune diseases in patients diagnosed with chronic myeloid leukemiaN Gunnarsson, M Höglund, L Stenke, et al.
Immuno-Oncology Technology|March 11, 2026
Safety of intratumoral immunostimulatory LOAd703 gene therapy combined with chemotherapy in patients with advanced cancerA Hahn, S Irenaeus, L C Sandin, et al.
Leukemia|May 3, 2016
Safety and efficacy of the combination of pegylated interferon-α2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patientsH Hjorth-Hansen, J Stentoft, J Richter, et al.
Leukemia|January 19, 2013
Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patientsS Mustjoki, J Richter, G Barbany, et al.
Leukemia|June 18, 2026
Comprehensive molecular characterization of treatment-free remission and molecular relapse in chronic myeloid leukemia patients: the EURO-SKI Biomarker StudyS Rinaldetti, M Chepeleva, A Hedblom, et al.
Leukemia|November 29, 2016
Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemiaM Ilander, U Olsson-Strömberg, H Schlums, et al.
Pageof 11